Accepted for/Published in: JMIR Research Protocols
Date Submitted: Sep 5, 2018
Open Peer Review Period: Sep 9, 2018 - Sep 23, 2018
Date Accepted: May 29, 2019
(closed for review but you can still tweet)
Preliminary effectiveness and safety of high frequency oscillation in addition to mechanical insufflation and exsufflation for intratracheal mucus removal in patients with neuromuscular disease: Protocol for prospective study
ABSTRACT
Background:
Mechanical insufflation–exsufflation (MI-E) is necessary for non-invasive management of respiratory clearance in patients with neuromuscular disorders (NMD). Its utility has been proven and the technique is recommended in a number of international guidelines for the management of patients with NMDs. However, the clearance of thick secretions adhering to the tracheobronchial walls could be problematic when these patients suffer from respiratory tract infections. To improve the effectiveness of the non-invasive technique, a novel device combining MI-E with high frequency oscillations (HFO) has been developed. However, the efficacy of HFO therapy in NMDs has not been well studied.
Objective:
The aim of this study is to elucidate the effect of MI-E combined with HFO for mucus removal in NMD patients. In order to evaluate its efficacy, changes in transcutaneous oxygen saturation (SpO2), which may predict intratracheal mucus removal, will be measured before and after use of MI-E.
Methods:
This is a single-center, non-blinded, non-randomized, prospective study that will enroll 5 subjects hospitalized in Kobe University Hospital due to respiratory tract infection. All subjects will receive MI-E therapy a few times daily, and HFO every other day, for 6 days. Before and after MI-E use, SpO2 will be obtained and the change in SpO2 (ΔSpO2) between MI-E with and without HFO will be calculated. For every subject, the average of ΔSpO2 with or without HFO will be obtained and the null hypothesis that there is mean change of 0 in the SpO2 between MI-E with and without HFO will be tested using the paired t-test. If the treatment with HFO is found to be statistically significantly superior to the treatment without HFO, the study will conclude that HFO addition is more efficacious than no HFO addition.
Results:
Two subjects have been already recruited and enrolled in this study by August 2018.
Conclusions:
This unique protocol will assess the efficacy of addition of HFO to MI-E during the acute phase of respiratory tract infection in patients with NMDs. Clinical Trial: University hospital Medical Information Network-Clinical Trial Registry (UMIN-CTR): UMIN000028080; http://www.umin.ac.jp/ctr/index-j.htm
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.